Larazotide 10mg
Tight-junction support for intestinal barrier research.
Larazotide 10mg cartridge — studied for its role in supporting intestinal tight junctions and gut barrier integrity.
- 3rd-party verified
- Cold-chain shipping
- Discreet packaging
- 99.8% purity
What it is
Larazotide acetate is an octapeptide zonulin antagonist researched for its ability to regulate intestinal permeability.
Key benefits
- Supports intestinal barrier integrity
- Helps regulate permeability ("leaky gut") pathways
- Complements gut-repair protocols
- Pairs well with BPC-157 in gut stacks
How it works
Larazotide blocks zonulin-mediated signalling, helping tight junctions between intestinal epithelial cells remain closed and reducing paracellular permeability.
Who it's best for
- Gut-repair and digestive comfort protocols
- Users pairing with BPC-157 or KPV
- Sensitivity and inflammation focused plans
Suggested protocol
Commonly used daily across 4–8 week research cycles.
Administration guide
Subcutaneous cartridge injection with site rotation.
Storage instructions
Refrigerate at 2–8 °C. Protect from light. Do not freeze.
Frequently asked questions
How quickly will I notice results from Larazotide?
Most users report measurable changes within 2–4 weeks of consistent use. Full results typically emerge across an 8–12 week protocol.
Can I stack this with other Peak Protocol products?
Yes. Our compounds are designed to be modular. Pair with complementary stacks from Recovery, Longevity, or Metabolic collections — our specialists can recommend a structure.
Is this third-party tested?
Every batch ships with a Certificate of Analysis verifying purity above 99% from an independent ISO-accredited lab.
What is the return policy?
Unopened, temperature-intact vials may be returned within 14 days. Opened compounds are non-returnable for safety reasons.
